These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28789461)

  • 1. Clinical significance of circulating microparticles in Ph
    Zhang W; Qi J; Zhao S; Shen W; Dai L; Han W; Huang M; Wang Z; Ruan C; Wu D; Han Y
    Oncol Lett; 2017 Aug; 14(2):2531-2536. PubMed ID: 28789461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Level of Circulating Microparticles in Patients with BCR/ABL Negative Myeloproliferative Neoplasm - a Pilot Study.
    Aswad MH; Kissová J; Rihova L; Zavrelova J; Ovesná P; Penka M
    Klin Onkol; 2019; 32(2):109-116. PubMed ID: 30995850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
    Duangnapasatit B; Rattarittamrong E; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Tantiworawit A; Norasetthada L
    Asian Pac J Cancer Prev; 2015; 16(12):5013-8. PubMed ID: 26163633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical Analysis of 208 Patiets with BCR/ABL Negative Myeloproliferative Neoplasms].
    Shen QH; Guo YJ; Xue CE; Wang Y; Lin FR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):159-164. PubMed ID: 30738463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased blood cell phosphatidylserine exposure and circulating microparticles contribute to procoagulant activity after carotid artery stenting.
    Zhao L; Wu X; Si Y; Yao Z; Dong Z; Novakovic VA; Guo L; Tong D; Chen H; Bi Y; Kou J; Shi H; Tian Y; Hu S; Zhou J; Shi J
    J Neurosurg; 2017 Nov; 127(5):1041-1054. PubMed ID: 28009236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK2V617F-Positive Endothelial Cells Induce Apoptosis and Release JAK2V617F-Positive Microparticles.
    Hekimoğlu H; Toprak SF; Sözer S
    Turk J Haematol; 2022 Feb; 39(1):13-21. PubMed ID: 34981912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Level of Microparticles in Patients with Essential Thrombocythemia and Its Relation with JAK2V617F Mutation].
    Zhao SX; Yang TH; Pei Q; Zhao RB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):2046-2050. PubMed ID: 33283740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing procoagulant activity of circulating microparticles in patients with Philadelphia-negative myeloproliferative neoplasms: a single-centre experience.
    Kissova J; Ovesna P; Bulikova A; Zavřelova J; Penka M
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):448-53. PubMed ID: 25828967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory significance of defective P2Y(12) pathway function in patients with myeloproliferative neoplasms: a pilot study.
    Chang H; Shih LY; Michelson AD; Dunn P; Frelinger AL; Wang PN; Kuo MC; Lin TL; Wu JH; Tang TC
    Acta Haematol; 2013; 130(3):181-7. PubMed ID: 23751441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinical Significance of Circulating Microparticles Concerning Thrombosis in BCR/ABL1-negative Myeloproliferative Neoplasms.
    Aswad MH; Kissova J; Ovesna P; Rihova L; Penka M
    In Vivo; 2021; 35(6):3345-3353. PubMed ID: 34697168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical Analysis of Driver Mutations in Patients with Ph Negative Myeloproliferative Neoplasms].
    He ZP; Tian HY; Tan M; Wu Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):842-848. PubMed ID: 29950230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
    Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
    Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annexin V
    Chen Y; Liu J; Su Y; Zhao H; Zhao Y; Wen M; Lu S; Cao X; Zhang W; Liu L; Wu J
    Clin Chim Acta; 2022 Nov; 536():169-179. PubMed ID: 36191610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms.
    Duchemin J; Ugo V; Ianotto JC; Lecucq L; Mercier B; Abgrall JF
    Thromb Res; 2010 Sep; 126(3):238-42. PubMed ID: 20656333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms.
    Taniguchi Y; Tanaka H; Luis EJ; Sakai K; Kumode T; Sano K; Serizawa K; Rai S; Morita Y; Hanamoto H; Tsubaki K; Nishio K; Matsumura I
    Int J Hematol; 2017 Nov; 106(5):691-703. PubMed ID: 28780601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera.
    Delic S; Rose D; Kern W; Nadarajah N; Haferlach C; Haferlach T; Meggendorfer M
    Br J Haematol; 2016 Nov; 175(3):419-426. PubMed ID: 27447873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microparticles as new markers of cardiovascular risk in diabetes and beyond.
    Santilli F; Marchisio M; Lanuti P; Boccatonda A; Miscia S; Davì G
    Thromb Haemost; 2016 Aug; 116(2):220-34. PubMed ID: 27173919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of Ph-negative myeloproliferative neoplasms in Ukraine.
    Mishcheniuk OY; Kostukevich OM; Dmytrenko IV; Sholoyko VV; Prokopenko IM; Martina ZV; Pilipenko GV; Klymenko SV
    Exp Oncol; 2013 Sep; 35(3):202-6. PubMed ID: 24084459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
    Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
    Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative characteristics of Philadelphia-negative myeloproliferative neoplasms - clinical implications.
    Šefer D; Bižić-Radulović S; Kraguljac-Kurtović N; Bogdanović A; Čokić V; Miljić P; Beleslin-Čokić B; Knežević V; Mitrović-Ajtić O; Leković D; Gotić M
    Int J Lab Hematol; 2017 Feb; 39(1):21-31. PubMed ID: 28025866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.